HENRY SCHEIN INC (HSIC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:HSIC • US8064071025

79.72 USD
+2.72 (+3.53%)
At close: Feb 6, 2026
79.72 USD
0 (0%)
After Hours: 2/6/2026, 4:43:19 PM
Fundamental Rating

4

Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 102 industry peers in the Health Care Providers & Services industry. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation. HSIC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HSIC was profitable.
  • HSIC had a positive operating cash flow in the past year.
  • HSIC had positive earnings in each of the past 5 years.
  • In the past 5 years HSIC always reported a positive cash flow from operatings.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • HSIC has a better Return On Assets (3.52%) than 65.69% of its industry peers.
  • HSIC has a Return On Equity of 11.63%. This is in the better half of the industry: HSIC outperforms 75.49% of its industry peers.
  • The Return On Invested Capital of HSIC (6.64%) is better than 65.69% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HSIC is in line with the industry average of 9.16%.
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROIC 6.64%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.02%, HSIC is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
  • In the last couple of years the Profit Margin of HSIC has declined.
  • HSIC's Operating Margin of 5.94% is fine compared to the rest of the industry. HSIC outperforms 65.69% of its industry peers.
  • In the last couple of years the Operating Margin of HSIC has declined.
  • With a Gross Margin value of 31.19%, HSIC perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
  • HSIC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
  • HSIC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HSIC is higher compared to a year ago.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • HSIC has an Altman-Z score of 2.66. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of HSIC (2.66) is comparable to the rest of the industry.
  • HSIC has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as HSIC would need 8.70 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 8.70, HSIC perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
  • HSIC has a Debt/Equity ratio of 0.91. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.91, HSIC perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Altman-Z 2.66
ROIC/WACC0.77
WACC8.58%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.40, HSIC perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
  • HSIC has a Quick Ratio of 1.40. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HSIC's Quick ratio of 0.79 is on the low side compared to the rest of the industry. HSIC is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.79
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 14.49% over the past year.
  • The Earnings Per Share has been growing slightly by 6.19% on average over the past years.
  • The Revenue has been growing slightly by 3.51% in the past year.
  • Measured over the past years, HSIC shows a small growth in Revenue. The Revenue has been growing by 4.88% on average per year.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%

3.2 Future

  • Based on estimates for the next years, HSIC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
  • Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.28% on average per year.
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue Next Year2.46%
Revenue Next 2Y2.94%
Revenue Next 3Y3.22%
Revenue Next 5Y3.28%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.54, the valuation of HSIC can be described as correct.
  • Based on the Price/Earnings ratio, HSIC is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (27.92), we can say HSIC is valued slightly cheaper.
  • HSIC is valuated correctly with a Price/Forward Earnings ratio of 14.75.
  • Based on the Price/Forward Earnings ratio, HSIC is valued cheaper than 80.39% of the companies in the same industry.
  • HSIC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.78.
Industry RankSector Rank
PE 16.54
Fwd PE 14.75
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSIC indicates a somewhat cheap valuation: HSIC is cheaper than 72.55% of the companies listed in the same industry.
  • HSIC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.36
EV/EBITDA 10.35
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.84
PEG (5Y)2.67
EPS Next 2Y6.79%
EPS Next 3Y7.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • HSIC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HENRY SCHEIN INC

NASDAQ:HSIC (2/6/2026, 4:43:19 PM)

After market: 79.72 0 (0%)

79.72

+2.72 (+3.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners97.45%
Inst Owner Change-0.93%
Ins Owners0.79%
Ins Owner Change-0.29%
Market Cap9.38B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts72.17
Price Target79.3 (-0.53%)
Short Float %5.07%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)5.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.18%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)2%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 16.54
Fwd PE 14.75
P/S 0.73
P/FCF 26.36
P/OCF 17.54
P/B 2.79
P/tB N/A
EV/EBITDA 10.35
EPS(TTM)4.82
EY6.05%
EPS(NY)5.41
Fwd EY6.78%
FCF(TTM)3.02
FCFY3.79%
OCF(TTM)4.54
OCFY5.7%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.84
PEG (5Y)2.67
Graham Number55.64
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROCE 9.68%
ROIC 6.64%
ROICexc 6.74%
ROICexgc 16.65%
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
FCFM 2.75%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Debt/EBITDA 2.85
Cap/Depr 58.69%
Cap/Sales 1.38%
Interest Coverage 5.16
Cash Conversion 49.81%
Profit Quality 91.05%
Current Ratio 1.4
Quick Ratio 0.79
Altman-Z 2.66
F-Score5
WACC8.58%
ROIC/WACC0.77
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.46%
Revenue Next 2Y2.94%
Revenue Next 3Y3.22%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.59%
EBIT Next 3Y8.39%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%

HENRY SCHEIN INC / HSIC FAQ

What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HSIC.


What is the valuation status of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.


Can you provide the profitability details for HENRY SCHEIN INC?

HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?

The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 16.54 and the Price/Book (PB) ratio is 2.79.


What is the earnings growth outlook for HENRY SCHEIN INC?

The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.82% in the next year.